Objective: The purpose of this scholarly review is to present an update of the efficacy, safety,
and distribution of intranasal corticosteroids (INCS) in the context of treatment for chronic …

Background Published randomized controlled trials (RCTs) on the efficacy of intranasal
corticosteroid (INCS) in chronic rhinosinusitis (CRS) use either nasal delivery (nasal drop or …

Objectives To address concerns related to the safety profile of both Food and Drug
Administration (FDA)–approved and non–FDA-approved intranasal corticosteroid (INCS) …

Objective To analyze published reports on the efficacy and safety of CSI in CRS and
evaluate the clinical implications of current gaps in evidence. Corticosteroid irrigation (CSI) …

Importance Practice guidelines have provided a strong recommendation for the daily use of
topical intranasal steroid therapy for patients with chronic rhinosinusitis (CRS). Deficiencies …

Background Guidelines from throughout the world recommend intranasal corticosteroids
(INSs) as first-line treatment for most patients with moderate to severe allergic rhinitis. In …

Purpose When first-line chronic rhinosinusitis (CRS) treatment fails, patients can either be
treated with oral or injected systemic corticosteroids. Although the EPOS and international …

Patients suffering from allergic rhinitis often attempt to self-manage their symptoms and may
seek advice from pharmacists about nonprescription product choices. Several drug classes …

Objective To systematically review the evidence base on the effectiveness of intranasal
corticosteroids in adult patients with recurrent acute rhinosinusitis. Data Sources Pubmed …

Objective: Chronic rhinosinusitis (CRS) is an inflammatory disease of the paranasal sinuses
and mucosa. Topical nasal corticosteroids are a mainstay treatment for CRS by reducing …